by | Nov 20, 2025 | Lupus Foundation of America, News & Events
A new groundbreaking study has recently identified the link between the long-standing mystery in autoimmune disease: Epstein-Barr Virus (EBV) and how it contributes towards the development of systemic lupus erythematosus (SLE). The study found that EBV infects a small...
by | Oct 26, 2025 | Lupus Foundation of America, News & Events
Today at the American College of Rheumatology (ACR) Annual Meeting, Convergence 2025, the ACR held a discussion of the new guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus. These guidelines provide an...
by | Oct 9, 2025 | Lupus Foundation of America, News & Events
A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes, which may serve as potential biomarkers for early detection and monitoring. SLE...
by | Oct 2, 2025 | Lupus Foundation of America, News & Events
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the Definition of Remission in SLE (DORIS remission). Many people did not reach...
by | Sep 22, 2025 | Lupus Foundation of America, News & Events
AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint. Trial results showed that subcutaneous administration of the therapy demonstrated a statistically...
by | Sep 12, 2025 | Lupus Foundation of America, News & Events
A new study has found a significant association between Epstein-Barr Virus (EBV), a highly contagious virus primarily spread through saliva, and systemic lupus erythematosus (SLE), highlighting a possible link in the virus’ role in SLE pathogenesis. People who are...
